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Abstract
Background: Lethal and edema toxins secreted by Bacillus anthracis during anthrax infection were found to incite
serious cardiovascular complications. However, the underlying mechanisms in anthrax lethal toxin-induced cardiac
anomalies remain unknown. This study was designed to evaluate the impact of antioxidant enzyme catalase in
anthrax lethal toxin-induced cardiomyocyte contractile dysfunction.
Methods: Wild type (WT) and cardiac-specific catalase overexpression mice were challenged with lethal toxin
(2 μg/g, intraperotineally (i.p.)). Cardiomyocyte contractile and intracellular Ca2+ properties were assessed 18 h later
using an IonOptix edge-detection system. Proteasome function was assessed using chymotrypsin-like and caspase-
like activities. GFP-LC3 puncta and Western blot analysis were used to evaluate autophagy and protein
ubiquitination.
Results: Lethal toxin exposure suppressed cardiomyocyte contractile function (suppressed peak shortening,
maximal velocity of shortening/re-lengthening, prolonged duration of shortening/re-lengthening, and impaired
intracellular Ca2+ handling), the effects of which were alleviated by catalase. In addition, lethal toxin triggered
autophagy, mitochondrial and ubiquitin-proteasome defects, the effects of which were mitigated by catalase.
Pretreatment of cardiomyocytes from catalase mice with the autophagy inducer rapamycin significantly attenuated
or ablated catalase-offered protection against lethal toxin-induced cardiomyocyte dysfunction. On the other hand,
the autophagy inhibitor 3-MA ablated or significantly attenuated lethal toxin-induced cardiomyocyte contractile
anomalies.
Conclusions: Our results suggest that catalase is protective against anthrax lethal toxin-induced cardiomyocyte
contractile and intracellular Ca2+ anomalies, possibly through regulation of autophagy and mitochondrial function.
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Background
The 2001 anthrax bioterrorism in the United States has
drawn the interest of the scientific community in under-
standing the pathophysiology of anthrax infection.
Anthrax is a pathological condition caused by a spore-
forming, Gram-positive bacterium Bacillus anthracis.
Infection by inhalation of B. anthracis spores can result
in a mortality rate up to 96% [1-3]. Major routes of infec-
tion have been confirmed through inhalation of, skin
contact with or ingestion of Bacillus anthracis spores.
Anthrax toxin is the major virulence factor of Bacillus
anthracis, containing three polypeptides, namely: edema
factor (EF), lethal factor (LF) and protective antigen (PA).
LF is a zinc metalloprotease which specifically cleaves
the NH2-terminal of mitogen-activated protein kinase
kinases resulting in inactivation of the kinases. EF is a
calmodulin-dependent adenylyl cyclase which promotes
intracellular cAMP accumulation and associated cellular
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responses [4-7]. PA binds the cellular receptors tumor
endothelial marker 8 and capillary morphogenesis pro-
tein 2 [8,9]. The combination of LF and the receptor
binding PA yields the lethal toxin [10]. Once bound to
the receptor and proteolytically activated, PA forms a
heptamer to deliver EF and/or LF to the cytoplasm fol-
lowing receptor-mediated endocytosis. Following anthrax
exposure, patients usually develop refractory hypotension
unresponsive to antibiotics, fluid, pressor and respiratory
support [11]. Anthrax lethal toxin was found to decrease
the heart rate, left ventricular ejection fraction and mean
arterial pressure [12,13]. In addition, anthrax lethal toxin
has been reported to directly compromise myocardial
function [14-17]. However, the underlying mechanisms
behind lethal toxin-induced unfavorable cardiac effects
remain elusive.
Accumulation of reactive oxygen species (ROS) has
been known to trigger cellular injury, including oxidation
of DNA and lipids, mitochondrial damage and dysregu-
lated autophagy [18,19]. Evidence suggests that anthrax
lethal toxin initiates ROS accumulation; in particular,
generation of superoxide and other ROS in macrophages
and neutrophils [14,20,21]. We previously reported that
anthrax lethal toxin stimulates myocardial superoxide
generation and thus impairs cardiac contractility [14]. To
this end, our present study was designed to examine the
effect of the antioxidant enzyme catalase on lethal toxin-
induced cardiac contractile anomalies and the underlying
mechanism. Catalase is an antioxidant enzyme convert-
ing hydrogen peroxide (H2O2) produced from highly
reactive superoxide (O2
-) by superoxide dismutase to
water and oxygen molecules. Given that autophagy has
been implicated in anthrax infection [14], essential pro-
tein markers for autophagy, including microtubule- asso-
ciated protein light chain 3 (LC3), Beclin-1, autophagy
related gene-7 (Atg-7) and green fluorescent protein-
tagged LC3 puncta (GFP-LC3), were monitored in myo-
cardial tissues or H9C2 myoblasts with or without lethal
toxin challenge. Given the pivotal role of ubiquitin-pro-
teasome system (UPS) in maintaining the protein synth-
esis and degradation parallel to the autophagic quality
control mechanism [22], proteasome function was
assessed using chymotrypsin-like and caspase-like
activities.
Methods
Generation of catalase overexpression transgenic mice
and production of anthrax lethal toxin
Catalase overexpressing transgenic mouse generation was
described in detail previously [23]. In brief, an 8-kb CAT
driven by a-myosin heavy chain (a-MHC) promoter con-
taining the entire coding sequences of the catalase cDNA
was purified on a matrix of diatomaceous earth (Prepa-
gene, Bio-Rad Hercules, CA, USA) and filtered through a
0.22-μm filter. Approximately, 100 copies of the purified
transgene insert were microinjected into one pronucleus
of each one-cell mouse embryo of the inbred strain FVB.
The transgene transcription of catalase was controlled by
the mouse a-MHC gene. To identify transgenic founder
mice, genomic DNA was isolated from 1-cm tail clips
from four-week-old mice. DNA was subjected to Southern
and dot blot analyses, which were probed with a 550-bp
SmaI/NotI fragment derived from the rat insulin II portion
of the CAT. This probe hybridized to an 8,000-bpEcoRI
fragment of the transgene, consistent with the presence of
a unique EcoRI site in the CAT (600-bp upstream of the
MHC transcription initiation site). Founder mice were
bred with mice of the same strain and transgenic offspring
were routinely identified by a polymerase chain reaction
(PCR) using a primer pair derived from the MHC promo-
ter and rat catalase cDNA with the reverse sequence of
AAT ATC GTG GGT GAC CTC AA and the forward
sequence of CAG ATG AAG CAG TGG AAG GA. These
transgenic mice have approximately 60-fold catalase
overexpression.
Recombinant PA and LF were produced and purified as
previously described [15,24,25]. In brief, plasmid pSJ115
encoding LF from SCS110 E. coli stocks was transformed
into BH445 crippled B. anthracis strain by electroporation
[24]. Single colonies from LB kanamycin agar plates were
grown overnight and 20 mL culture media were inocu-
lated into 6 L modified FA media in the presence of 1 mL
polypropylene glycol P200 and kanamycin at 37°C at 100
to 300 rpm agitation rate and 2 L air/min constant spar-
ging for 14 h. Cultures were centrifuged, and 2 mM
EDTA and 0.1 mM PMSF added to supernatant. Superna-
tants were sterilized using 0.22-μm filters and concen-
trated to 300 mL with 10,000 Da Mr cutoff cellulose
membranes in a Pellicon system. A total of 40% ammo-
nium sulfate was added, and the sample was loaded,
washed and eluted from Fast Flow PhenylSepharose six
columns with a 1.5 to 0 M ammonium sulfate gradient in
20 mM Hepes/5 mM EDTA pH 7.5. LF containing frac-
tions were concentrated in Centricon Plus-80, dialyzed
into 20 mM Hepes/0.1 mM EDTA pH 8, and eluted from
a Q-Sepharose Fast Flow column with a 0 to 0.5 M NaCl
in 10 mM Tris/0.5 mM EDTA pH 8 gradient. Eluted LF
fractions were pooled, concentrated again with Centricon
Plus-80 filters, diluted in 1x PBS, filter sterilized and fro-
zen at -80°C. pYS5-wild-type PA vector was transformed
into B. anthracis as described above. Colonies were
expanded in overnight cultures with kanamycin and were
inoculated into 6 L modified FA medium with polypropy-
lene glycol and kanamycin for LF and PA fermentation
similar to LF [25]. After 14 h, cultures were centrifuged
prior to the addition of EDTA and PMSF. Filtration and
concentration were conducted using a Pellicon system. A
total of 20% ammonium sulfate was added, and PA loaded,
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washed and eluted from Phenyl Sepharose Fast Flow with
a 1.5 to 0 M ammonium sulfate gradient in 10 mM
HEPES/5 mM EDTA pH 7. PA containing fractions were
dialyzed against 20 mM Tris/5 mM EDTA pH 8.9 and
loaded and eluted from a Q Sepharose Fast Flow column
with a 0 to 0.5 M NaCl in 20 mM Tris/5 mM EDTA pH
8.9 gradient. Pooled PA fractions were purified using the
Superdex 75 chromatography in PBS/5 mM EDTA pH 7.4
and were pooled, concentrated with Centricon Plus-80 fil-
ters, diluted in 1x PBS, filter sterilized and frozen at -80°C
until experimentation. Immediately before in vivo injec-
tion, toxin components were thawed and mixed in PBS.
Experimental animals and anthrax lethal toxin challenge
All animal procedures used in this study were approved
by the Animal Care and Use Committee at the Univer-
sity of Wyoming (Laramie, WY, USA). Animals were
housed under well-controlled conditions of temperature
(22 ± 2°C), humidity (55 ± 5%) and circadian cycle (12
h/12 h light-dark) with access to food and water ad libi-
tum. Four month-old adult male cardiac-specific catalase
overexpressing (CAT) mice and their wild-type (WT)
littermates were used. For lethal toxin challenge, mice
were injected intraperitoneally with PBS or anthrax
lethal toxin (2 μg/g) (LF + PA 1:2 ratio) and were sacri-
ficed 18 h following in vivo lethal toxin injection [14].
Murine cardiomyocyte isolation and drug treatments
After ketamine/xylazine (80 mg/kg:12 mg/kg, i.p.) seda-
tion, hearts were removed and perfused with Ca2+ -free
Tyrode’s solution containing (in mM): NaCl 135, KCl 4.0,
MgCl2 1.0, HEPES 10, NaH2PO4 0.33, glucose 10, butane-
dione monoxime 10 and the solution was gassed with 5%
CO2/95% O2. Hearts were digested with Liberase Blend-
zyme 4 (Hoffmann-La Roche Inc., Indianapolis, IN, USA)
for 20 minutes. Left ventricles were removed and minced
before being filtered. Extracellular Ca2+ was added incre-
mentally back to 1.20 mM over a period of 30 minutes.
Myocyte yield was approximately 75%, which was not
affected by either lethal toxin challenge or catalase overex-
pression. Only rod-shaped myocytes with clear edges were
selected for mechanical study [14]. To assess the cause-
effect relationship of autophagy in lethal toxin-induced
cardiomyocyte anomalies, in vitro studies were performed
using cardiomyocytes isolated from WT and catalase
transgenic mice treated with or without lethal toxin
(100 ng/ml) at 37°C for 3 h in the presence or absence of
the autophagy inhibitor 3-methyladenine (3-MA, 10 mM)
or the autophagy inducer rapamycin (5 μM) prior to
mechanical and biochemical evaluation [26].
Cell shortening and relengthening
Mechanical properties of cardiomyocytes were evaluated
using a MyoCam system (IonOptix Corporation, Milton,
MA, USA) [14]. Briefly, cardiomyocytes were visualized
under an inverted microscope (IX-70, Olympus Optical
Co., Tokyo, Japan) and were stimulated at a frequency
of 0.5 Hz. The myocyte being observed was displayed
on a computer monitor using an IonOptix MyoCam
camera (IonOptix Corporation, Milton, MA, USA).
IonOptix SoftEdge software was utilized to capture cell
shortening and re-lengthening. The indices measured
included peak shortening (PS), time-to-peak shortening
(TPS), time-to-90% re-lengthening (TR90), and maximal
velocity of shortening/re-lengthening (± dL/dt).
Intracellular Ca2+ transients
Isolated cardiomyocytes were loaded with fura-2/AM
(0.5 μM) for 10 minutes. Fluorescence intensity was
recorded with a dual-excitation fluorescence photomulti-
plier system (IonOptix). Myocytes were placed onto an
Olympus IX-70 inverted microscope and imaged through
a Fluor 40x objective. Cells were exposed to light emitted
by a 75 W lamp and passed through either a 360 or a
380 nm filter while being stimulated to contract at 0.5 Hz.
Fluorescence emissions were detected between 480 and
520 nm, and qualitative change in fura-2 fluorescence
intensity was inferred from the fura-2 fluorescence inten-
sity ratio at 360 and 380 nm. Fluorescence decay time
(both single and bi-exponential curve fits) was calculated
as an indicator of intracellular Ca2+ clearing [14].
Measurement of O2
- levels in myocardium
In situ production of myocardial O2
- was assessed using
the oxidative fluorescent dye dihydroethidium (DHE)
[14]. The cell membrane permeable DHE is oxidized to
fluorescent hydroxyethidine by O2
- and then intercalated
into DNA. In brief, myocardial tissues were placed in ice-
cold PBS, rinsed and embedded in the optimal cutting
temperature (OCT) compound medium (Sakura Finetek
USA, Inc., Torrance, CA, USA) for cryosectioning. The
cryomoulds were stored at -80°C. Sections (30 μm) from
the cryomoulds were thawed to room temperature and
were incubated with DHE (10 μM) for 45 minutes at
room temperature in a dark chamber. After being washed
three times with PBS, sections were fixed with aqueous
mounting medium (VectaMount AQ, Vector Labora-
tories, Burlingame, CA, USA) and images were obtained
using a Zeiss LSM 710 confocal microscope (Carl Zeiss
MicroImaging GmbH, Jena, Germany). Nuclei with red
fluorescence were measured using the ImageJ analysis
software (version 1.34S, developed by NIH).
Measurement of ROS production
Production of cellular reactive oxygen species (ROS) was
evaluated by analyzing the changes in fluorescence inten-
sity resulting from oxidation of the intracellular fluorop-
robe 5-(6)-chloromethyl-2, 7-dichlorodihydrofluorescein
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diacetate (CM-H2DCFDA). In brief, cardiomyocytes were
isolated from WT and catalase transgenic mice chal-
lenged with or without lethal toxin (2 μg/g, i.p., for 18 h)
and were loaded with 10 μM of the nonfluorescent dye
CM-H2DCFDA (Molecular Probes, Eugene, OR, USA) at
37°C for 30 minutes. The myocytes were rinsed with
KRH buffer (125 mM NaCl, 5 mM KCl, 1.8 mM CaCl2,
2.6 mM MgSO4, 5 mM HEPES, pH 7.4) and the fluores-
cence intensity was then measured with a SpectraMax
XS fluorescence microplate spectrophotometer (Spectra
MaxGeminiXS, spectra Max, Atlanta, GA, USA) at an
excitation wavelength of 480 nm and an emission wave-
length of 530 nm. Sections (30 μm) of frozen tissues were
thawed to room temperature and were incubated with
CM-H2DCFDA (10 μM) for 1 h at room temperature in
a dark chamber. After being washed three times with
PBS, sections were fixed with aqueous mounting medium
(VectaMount AQ, Vector Laboratories) and images were
obtained using a Zeiss LSM 710 confocal microscope
(Carl Zeiss MicroImaging GmbH, Jena, Germany) [27].
Cell culture
H9C2 cells, a clonal cell line derived from fetal rat heart,
purchased from ATCC (Manassas, VA, USA). Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) (Gibco,
Grand Island, NY, USA) and 1% penicillin and streptomy-
cin and maintained in 95% air and 5% CO2 at 37
°C. Cells
were grown to 80% confluence before treating with
anthrax lethal-toxin [14].
Measurement of mitochondrial membrane potential (ΔΨm)
Murine cardiomyocytes from lethal toxin-treated mice or
H9C2 cells following in vitro lethal-toxin treatment
(100 ng/ml for 1 h) were incubated with JC-1 (5 μM) for
15 minutes at 37°C. Fluorescence was analyzed with a
Texas red-FITC filter cube (Spectra MaxGeminiXS, spectra
Max, Atlanta, GA, USA). Red emission represents a poten-
tial-dependent aggregation in the mitochondria, reflecting
ΔΨm. Green fluorescence represented the monomeric
form of JC-1, appearing in the cytosol after mitochondrial
membrane depolarization. Fluorescence of each sample
was read at an excitation wavelength of 490 nm and emis-
sion wavelength of 530 (Green) and 590 (Red) nm using a
spectrofluorimeter (Spectra MaxGeminiXS, spectra Max,
Atlanta, GA, USA) at an interval of 10 sec. Results in fluor-
escence intensity were expressed as 590-to-530 nm emis-
sion ratio. The mitochondrial uncoupler carbonyl cyanide
m-cholorophenylhydrazone (CCCP, 50 μmol/L) was used
as a positive control for ΔΨm measurement [28].
Proteasome activity
Proteasome activity was measured as described [29].
Briefly, heart tissues were homogenized in HEPES buffer
(in mM: NaCl 137, KCl 4.6, KH2PO4 1.1, MgSO4 0.6,
EDTA 1, and DTT 1) without protease inhibitor at 4°C
and then centrifuged at 16,168 g to obtain the soluble
fraction. Protein (50 μg in 50 μl) was incubated in 50 μl
of 50 mM Tris-HCl buffer, pH 7.5, containing 20 mM
KCl, 0.5 mM MgCl2 and 1 mM DTT for 1 h with
200 μM fluorogenic substrates Suc-LLVY-AMC/Z-LLE-
AMC (Enzo Life Sciences, Plymouth Meeting, PA,
USA). Fluorescence products were measured using a
spectrofluorimeter (Spectra MaxGeminiXS, spectra Max,
Atlanta, GA, USA) using a 355-nm excitation and
460-nm emission filter.
LC3B-GFP-adenovirus production and infection
Adenovirus containing LC3-GFP construct (GFP tagged
on the N-terminal of LC3) was kindly provided by
Dr. Cindy Miranti (Van Andel Institute, Grand Rapids,
MI, USA) and was propagated using HEK293 cell line.
Briefly, cells were infected with LC3-GFP adenovirus and
collected upon plaque formation. Cell debris was collected
by centrifugation, and aliquots of supernatant with viral
particles were stored at -80°C. Adenovirus was purified
using an Adeno-X Maxi purification kit from Clontech
(Clontech Laboratories, Inc., Mountain View, CA, USA).
H9C2 cells were grown to confluence on Lab-Tek cham-
ber slides. Cells were then infected at an MOI of 2 with
adenoviruses expressing LC3-GFP fusion protein. Medium
was replaced with fresh DMEM after 6 h. Twenty four
hours later, cells were observed for autophagy using confo-
cal microscopy [14].
Quantification of GFP-LC3
H9C2 cells transfected with GFP-LC3 adenovirus were
treated with or without anthrax lethal toxin (100 ng/ml).
Cells were fixed with 4% paraformaldehyde in PBS for
20 minutes at room temperature. Cells were then
washed with PBS three times. These fixed cells were
treated with DAPI for five minutes followed by three
washes with PBS. Cover slips were mounted on slides
using Vecta mount™ AQ-aqueous mounting medium
(Vector Laboratories, Inc.,). For analysis of autophagy,
cells were visualized at 40x magnification using a Zeiss
LSM 710 confocal microscope (Carl Zeiss MicroImaging
GmbH, Jena, Germany) and the percentage of cells
showing numerous GFP-LC3 puncta (>10 dots/cells)
were scored as described previously [30]. A minimum of
75 to 100 cells were scored for each condition in at
least three independent experiments.
Western blot analysis
Protein samples for Western blot analysis were prepared
as described [14]. Briefly, ventricular tissues or H9C2
cells were homogenized and sonicated in a lysis buffer
containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM
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ethylenediaminetetraacetic acid (EDTA), 1 mM ethylene-
glycoltetraacetic acid (EGTA), 1% Triton, 0.1% SDS and
1% protease inhibitor cocktail. Equal amounts (50 μg) of
proteins were separated on 7% to 15% SDS-polyacryla-
mide gels in a minigel apparatus (Mini-PROTEAN II,
Bio-Rad Laboratories Inc.,) and were transferred electro-
phoretically to nitrocellulose membranes. The mem-
branes were blocked with 5% milk in Tris-buffered saline
before overnight incubation at 4°C with anti-Beclin-1
(1:1,000), anti-Atg-7 (1:1,000), anti-LC3-II (1:1,000), anti-
phospholamban (1:1,000), anti-phosphorylated phospho-
lamban (1:1,000), anti-SERCA2a (1:1,000), anti-Na+-Ca2+
exchanger (NCX, 1:1,000), anti-ubiquitin (1:1000), and
anti-GAPDH (loading control, 1:1,000) antibodies.
Proteins were visualized after subsequent incubation with
a 1:5,000 dilution of anti-mouse or anti-rabbit IgG conju-
gated to horseradish peroxidase and a LumiGLO® Che-
miluminescence detection procedure (Cell Signaling
Technologies, Beverly, MA, USA).
Statistical analysis
Data were expressed as mean ± SEM. Statistical signifi-
cance (P <0.05) for each variable was estimated by ana-
lysis of variance (ANOVA) followed by the Tukey’s test
for post-hoc analysis.
Results
Effect of lethal toxin challenge on survival rate and
cardiomyocyte mechanics in FVB and catalase transgenic
mice
The Kaplan-Meier survival curve depicts that catalase
transgenic mice survived approximately 8 h longer than
WT mice although there was 100% mortality ultimately in
WT and catalase transgenic mice following lethal toxin
treatment (Figure 1A). Lethal toxin challenge significantly
reduced peak shortening (PS) and maximal velocity of
shortening/re-lengthening (±dL/dt) as well as prolonged
time-to-PS (TPS) and time-to-90% re-lengthening (TR90)
in WT cardiomyocytes, the effect of which was either sig-
nificantly attenuated or ablated by catalase overexpression.
Catalase overexpression itself failed to affect the cardio-
myocyte mechanics tested (Figure 1B-F). To explore the
potential mechanisms of action behind lethal toxin-
induced cardiomyocyte mechanical abnormalities, intracel-
lular Ca2+ handling was evaluated using fura-2 fluores-
cence in cardiomyocytes from WT and catalase transgenic
mice with or without lethal toxin exposure. Cardiomyo-
cytes from catalase transgenic mice displayed subtle but
significant higher basal intracellular Ca2+ levels although
none of the other intracellular Ca2+ indices was altered by
catalase overexpression. Lethal toxin exposure significantly
prolonged intracellular Ca2+ decay rate (both single and
bi-exponential curve fit) without affecting the resting and
electrically stimulated rise in intracellular Ca2+ levels, the
effects of challenge were significantly attenuated or ablated
by catalase overexpression (Figure 2).
Effect of lethal toxin and catalase overexpression on
intracellular Ca2+ regulatory proteins
To further determine the mechanism underscoring lethal
toxin exposure- and catalase overexpression-elicited
changes in intracellular Ca2+ homeostasis, levels of intra-
cellular Ca2+ regulatory proteins including SERCA2a, Na
+-Ca2+ exchanger and the SERCA inhibitory protein phos-
pholamban were examined. Our data shown in Additional
file 1, Figure S1 revealed that neither lethal toxin nor cata-
lase, or both, affected levels of SERCA2a, Na+-Ca2+
exchanger and phospholamban (or its phosphorylation).
Effect of catalase overexpression on lethal toxin
exposure-induced O2
- and ROS production
O2
- production was significantly elevated in myocardium
from lethal toxin-treated WT mice, the effect of which
was significantly attenuated by catalase overexpression
with little effect of catalase by itself (Figure 3A-B). In
addition, our data depicted that lethal toxin significantly
elevated ROS generation in WT cardiomyocytes, the
effect of which was mitigated by catalase overexpression.
Catalase overexpression itself did not affect ROS produc-
tion (Figure 3C-D).
Effect of catalase overexpression on lethal toxin
exposure-induced mitochondrial dysfunction
Mitochondrial membrane potential (ΔΨm) is well known
as an essential indicator for mitochondrial and ultimately
cardiomyocyte viability and function [31]. The cationic
lipophilic probe JC-1 was employed to monitor ΔΨm in
response to lethal toxin treatment. The dynamic change of
ΔΨm was displayed by changes in the red (aggregated JC-
1) and green (monomeric form of JC-1) fluorescence.
Quantitative analysis exhibited a significant reduction in
the ratio between the red and green fluorescence in
response to lethal toxin treatment, indicating a fall in
ΔΨm and mitochondrial damage. Interestingly, the lethal
toxin-induced fall in ΔΨm was abrogated by catalase over-
expression. Catalase overexpression itself did not exert any
significant effect on ΔΨm (Figure 4).
Effect of catalase overexpression on lethal toxin-induced
ubiquitin-proteasome dysfunction
Protein degradation by the ubiquitin-proteasome system
involves attachment of multiple ubiquitin molecules to
substrate protein followed by degradation of the tagged
protein by the 26S proteasome complex. Basal ubiquitina-
tion in hearts from WT and catalase transgenic mice was
comparable. Interestingly, lethal toxin exposure signifi-
cantly up-regulated ubiquitination while it down-regulated
proteasome activity as measured by chymotrypisn-like and
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Figure 1 Effect of LeTx on survival rate and cell shortening in cardiomyocytes from WT and catalase mice. A: Survival rate (%); B: Peak
shortening (PS, normalized to resting cell length); C: Maximum velocity of shortening (+ dL/dt); D: Maximum velocity of relengthening (-dL/dt);
E: time-to-peak shortening (TPS); and F: time-to-90% re-lengthening (TR90). For panel A; n = 8 mice per group. For panel B-F data were
presented as Mean ± SEM, n = 100 to 150 cells from two to three mice per group, *P <0.05 vs. WT group, # P <0.05 vs. WT-LeTx group.
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caspase-like activities in WT mice. Catalase overexpres-
sion abrogated lethal toxin-induced increase in ubiquitina-
tion and decrease in chymotrypsin-like and caspase-like
activities. Similarly, isolated cardiomyocytes treated with
H2O2 (250 μM) for 2 h elicited a significant inhibition of
both chymotrypsin- and caspase-like activities, the effect
of which was ablated by the pretreatment with the antioxi-
dant N-acetyl-cysteine (NAC, 500 μM) (Figure 5).
Effect of anthrax lethal toxin on autophagosome
formation
To evaluate autophagosome formation in response to
lethal toxin exposure, GFP tagged onto the N-terminal of
LC3 (GFP-LC3) was used as a surrogate marker in H9C2
cells. With activation of autophagy, GFP-LC3-I is pro-
cessed to GFP-LC3-II before getting recruited onto the
autophagosome membrane (shown as punctuate using
fluorescence microscopy). Our data revealed that lethal
toxin treatment (25 to 200 ng/ml for 3 h) triggered signifi-
cant up-regulation of LC3-II levels in a concentration
dependent manner (Figure 6A). Lethal toxin (100 ng/ml)
caused a significant up-regulation of autophagosome for-
mation and LC3-II expression levels (Figure 6B-D). These
results clearly indicated that lethal toxin induced overt
autophagy.
Effect of catalase overexpression on lethal toxin
exposure-induced autophagy
Overt autophagy has been implicated in cardiovascular
complications [18]. LC3 exists in two forms, a 16-kDa
cytosolic form (LC3-I) and a 14-kDa processed form
(LC3-II) localized on autophagosome membrane [32].
Figure 2 Effect of LeTx on intracellular Ca2+ transients in cardiomyocytes from WT and catalase mice. A: Resting fura-2 fluorescence intensity
(FFI); B: electrically stimulated rise in FFI (ΔFFI); C: Single exponential intracellular Ca2+ transient decay rate; and D: Bi-exponential intracellular Ca2+
transient decay rate. Mean ± SEM, n = 60 to 75 cells from two to three mice per group, *P <0.05 vs. WT group, #P <0.05 vs. WT-LeTx group.
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Our data revealed elevated LC3-II levels without signifi-
cant changes in the levels of Beclin-1 and Atg-7 in WT
myocardium following lethal toxin exposure. Catalase
transgenic overexpression itself did not significantly
alter the expression of autophagic protein markers.
However, catalase significantly attenuated lethal toxin-
induced increase in LC3-II levels (Figure 7).
Effect of ROS inhibition on lethal toxin-induced changes
in autophagy proteins
To further consolidate the role of ROS in lethal toxin-
induced autophagy, levels of Beclin-1, Atg-7 and LC3-II
were determined. Lethal toxin exposure elicited significant
up-regulation of LC3-II expression without affecting
Beclin-1 and Atg-7. Interestingly, pretreatment with anti-
oxidant NAC obliterated the lethal toxin-induced rise in
LC3-II. NAC itself did not affect the expression of autop-
hagy markers with the exception of a subtle, although sig-
nificant, reduction in Beclin-1 level. These data favor a
role of ROS in lethal toxin-induced autophagosome
formation (Figure 8A-D).
Effect of lethal toxin, 3-MA and rapamycin on
cardiomyocyte contractile function
To further examine the causal role of autophagy in lethal
toxin-induced contractile response, cardiomyocytes from
Figure 3 Effect of catalase (CAT) overexpression on LeTx-induced generation of O2
- and ROS. A: Representative images depicting DHE
fluorescence in myocardium from WT and catalase transgenic mice treated with or without lethal toxin. B: Pooled data of O2
- production; C:
Representative images depicting DCF fluorescence in myocardium from WT and catalase transgenic mice; and D: ROS levels in isolated
cardiomyocytes from WT and catalase transgenic mice treated with or without lethal toxin. Mean ± SEM, n = 3 mice (panel B) or 6 isolations
(panel D) per group, *P <0.05 vs. WT group, #P <0.05 vs. WT-LeTx group.
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WT and catalase transgenic mice were treated with or
without lethal toxin in the absence or presence of the
autophagy inducer rapamycin (5 μM) or the autophagy
inhibitor 3-MA (10 mM). Our data showed that lethal
toxin significantly depressed PS, ± dL/dt and prolonged
TR90 without affecting resting cell length and TPS in WT
cardiomyocytes, the effects of which were ablated or
significantly attenuated by catalase overexpression. Inter-
estingly, pretreatment of cardiomyocytes from catalase
transgenic mice with rapamycin prior to lethal toxin
exposure significantly attenuated or ablated catalase-
offered protection against a lethal toxin-induced defect.
To the contrary, the autophagy inhibitor 3-MA effectively
ablated or significantly attenuated lethal toxin-induced
Figure 4 Effect of catalase (CAT) overexpression on LeTx-induced cardiomyocyte mitochondrial damage. A: Representative fluorescent
images of JC-1 in control and LeTx exposure conditions. CCCP (10 μM) was used as a positive control; B: Summarized JC-1 ratio representing
mitochondrial membrane potential in response to LeTx and CCCP exposure; and C: Cardiomyocyte mitochondrial membrane potential over time.
Mean ± SEM, n = 6 isolations per group, *P <0.05 vs. WT group, #P <0.05 vs. WT-LeTx group.
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cardiomyocyte mechanical abnormalities (Figure 8E-H,
Additional file 1 Figure S2). These data revealed a per-
missive role of autophagy in lethal toxin-induced cardio-
myocyte contractile anomalies.
Discussion
The salient findings of our study are that anthrax lethal
toxin exposure elicits enhanced ROS accumulation,
myocardial contractile dysfunction, impaired intracellu-
lar Ca2+ handling, decreased mitochondrial membrane
potential, enhanced ubiquitination and overt autophagy.
Intriguingly, cardiac catalase overexpression abrogated
or attenuated anthrax lethal toxin-induced cardiac con-
tractile and intracellular Ca2+ anomalies. The catalase-
offered beneficial effects against lethal toxin were closely
associated with the alleviation of lethal toxin-induced
Figure 5 Effect of catalase (CAT) overexpression and antioxidant on LeTx-induced changes in ubiquitin-proteasome activity. Expression
and activity of the ubiquitin-proteasome system were determined in myocardium from WT and catalase transgenic mice treated with or without
lethal toxin. For positive control, a cohort of isolated cardiomyocytes from WT mice were incubated with H2O2 (250 μM) for 2 h in the presence
or absence of the antioxidant NAC (500 μM). A: Representative gel blots in triplicates depicting ubiquitination; B: Ubiquitin expression; C:
Chymotrypsin-like activity; and D: Caspase-like activity. Mean ± SEM, n = 6 mice or isolations per group, *P <0.05 vs. WT group, #P <0.05 vs. WT-
LeTx group, ψ P <0.05 vs. WT-H2O2 group.
Kandadi et al. BMC Medicine 2012, 10:134
http://www.biomedcentral.com/1741-7015/10/134
Page 10 of 16
accumulation of O2
- and ROS, loss of mitochondrial
membrane potential, increase in ubiquitination, decrease
in proteasome activity and induction of autophagy,
depicting a possible role autophagy and mitochondrial
integrity in catalase-offered protection against lethal
toxin. Our data further revealed that autophagy induc-
tion mitigated catalase-offered a cardioprotective effect,
consistent with the finding of obliteration of lethal
toxin-induced cardiomyocyte contractile anomalies.
These findings collectively support a causal role of
autophagy in lethal toxin-induced cardiac injury and
catalase enzyme-offered cardioprotection.
Ample experimental evidence has revealed hemody-
namic and cardiac anomalies following anthrax exposure
[1,13-15,17,33,34]. Data from our current study revealed
that anthrax lethal toxin inhibits cardiomyocyte contrac-
tile function and intracellular Ca2+ handling including
depressed peak shortening amplitude and maximal velo-
city of shortening/re-lengthening, prolonged duration of
re-lengthening as well as reduced electrically-stimulated
intracellular Ca2+ rise (ΔFFI), and delayed intracellular
Ca2+ clearance. These results are consistent with our
previous report [14]. Intriguingly, lethal toxin-induced
anomalies in cardiac contractile and intracellular Ca2+
properties were significantly attenuated or mitigated by
overexpression of the antioxidant catalase. These find-
ings denote a possible role of intracellular Ca2+ homeos-
tasis in lethal toxin- and/or catalase-elicited mechanical
responses. Our observations of unchanged intracellular
Ca2+ regulatory proteins, including SERCA2a, Na+-Ca2+
Figure 6 Effect of LeTx on autophagosome formation. A: LC3-II in H9C2 cells treated with different concentrations of lethal toxin (25 to 200
ng/ml); B: LC3-II in H9C2 cells treated with 100 ng/ml lethal toxin for different durations of times (1 to 9 h). Inserts depicting expression LC3-I/II
and GAPDH (loading control); C: Representative fluorescent microscopic images of GFP-LC3-II (DAPI’s blue staining depicts nucleus; white arrows
points autophagosomes); D: Quantitation of number of autophagosome per cell. Mean ± SEM, n = 3 independent cultures, *P <0.05 vs. Control.
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exchanger and phospholamban, were consistent with
our earlier report [14], suggesting possible involvement
of certain post-translational modification process in
these intracellular Ca2+ regulatory proteins en route to
altered intracellular Ca2+ homeostasis. In our hands, cat-
alase overexpression alleviated lethal toxin-induced oxi-
dative stress (O2
- and ROS) and autophagy, favoring a
possible role of oxidative modification and autophagy
regulation in intracellular Ca2+ homeostasis in our
experimental setting.
Autophagy is a tightly regulated cellular process through
which mammalian cells degrade and recycle protein aggre-
gates and organelles [18]. Under physiological conditions,
autophagy helps to maintain the amino acid pool during
starvation, and prevents neurodegeneration, aging and
tumor development through clearance of intracellular
microbes [18,35,36]. Impaired autophagy is often asso-
ciated with cardiac diseases due to poor autophagic
removal of damaged cellular components [35]. Autophagy
can be activated by pathophysiological stress stimuli such
as, hypoxia, energy depletion and ER stress as well as bac-
terial, viral and parasite infections [35,36]. Although up-
regulated autophagy serves to offset cardiac hypertrophy
via protein degradation [37,38], excessive autophagy
usually compromises cardiomyocyte survival and subse-
quently ventricular function. Enhanced autophagy is
observed in failing hearts and a wide array of cardiovascu-
lar diseases resulting in cardiac death and impaired cardiac
performance [39-41]. Data from our study revealed that
lethal toxin exposure induced overt myocardial autophagy,
the effect of which was mitigated by catalase overexpres-
sion and NAC. More importantly, our data revealed that
induction of autophagy with rapamycin nullified the cardi-
oprotective benefit of catalase overexpression against lethal
toxin whereas autophagy inhibition using 3-MA mimicked
catalase-elicited beneficial effect. These data convincingly
Figure 7 Effect of catalase (CAT) overexpression on LeTx-induced autophagy. A: Representative gel blot depicting expression of Beclin-1,
Atg-7, LC3-I/II and GAPDH (loading control); Triplicates in the gel blot represents samples from three mice of each treatment group. B: Beclin-1;
C: Atg-7; and D: LC3-II. Mean ± SEM, n = 6 mice per group, *P <0.05 vs. WT group, #P <0.05 vs. WT-LeTx group.
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Figure 8 Effect of ROS inhibition on lethal toxin-induced autophagy. A-D: Isolated cardiomyocytes were incubated with LeTx (100 ng/ml)
for 3 h in the absence or presence of the NAC (500 μM). A: Representative gel blots depicting expression of Beclin-1, Atg-7, LC-3 and GAPDH
(used as loading control); B: Beclin-1; C: Atg-7; D: LC3-II. Each lane in a treatment group on the gel represents sample from independent
experiment. Mean ± SEM, n = 4 independent isolations per group, *P <0.05 vs. control group, # P <0.05 vs. LeTx group. Effect of autophagy
induction or inhibition on lethal toxin induced cardiac contractile dysfunction. E-J: Isolated cardiomyocytes from WT and CAT mice were
incubated with lethal toxin (100 ng/ml) for 3 h in presence or absence of the autophagy inhibitor 3-methyladenine (3-MA, 10 mM) or autophagy
inducer rapamycin (5 μM) respectively. E: Peak shortening (PS, normalized to resting cell length); F: Maximum velocity of shortening (+ dL/dt); G:
Maximum velocity of relengthening (- dL/dt); H: time-to-90% re-lengthening (TR90). Mean ± SEM, n = 60 to 75 cells from three mice per group,
*P <0.05 vs. WT group, # P <0.05 vs. WT-LeTx group.
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support a causality relationship of autophagy in lethal
toxin- and catalase enzyme-induced cardiac mechanical
responses. The fact that NAC ablated lethal toxin-induced
up-regulated in autophagy (Figure 8A-D) further depicts a
permissive role of oxidative stress in lethal toxin-induced
induction of autophagy. ROS has been shown to activate
starvation-induced autophagy, antibacterial autophagy and
autophagic cell death through distinct mechanisms,
depending on cell types and stimulation conditions [42]. It
is unclear at this time why NAC treatment itself lowered
Beclin-1 levels, which may be related to intercellular redox
state-governed autophagy initiation.
Mitochondrion plays a pivotal role in energy genera-
tion, intracellular Ca2+ homeostasis and ROS production
[43,44]. In addition to its primary function for energy
generation to meet the high demand of the beating heart,
mitochondria also regulates cell death in response to a
wide variety of stress signals, such as oxidative stress,
infection and DNA damage [45]. Anthrax lethal toxin sti-
mulates ROS production in macrophages and cardiomyo-
cytes [14]. It was also shown that mitochondrial
impairment is a critical event leading to macrophage
cytolysis during anthrax toxin exposure [46]. This is also
supported by our early finding of the involvement of
NADPH oxidase, a mitochondrial-based O2
--generating
enzyme, in lethal toxin-induced cardiac anomalies [14].
Data from our study revealed that anthrax lethal toxin
exposure stimulates O2
- and ROS generation and reduces
mitochondrial membrane potential. Interestingly, lethal
toxin-induced changes in O2
-, ROS and mitochondrial
membrane potential were attenuated or ablated by cata-
lase overexpression, suggesting a likely role of mitochon-
dria in catalase-offered protection against lethal toxin
exposure. Nonetheless, it is surprising for the catalase
enzyme to attenuate the catalase-resistant O2
- generation.
Although the precise mechanism responsible for such
unexpected inhibition is still elusive at this time, a couple
of scenarios may be considered. It is possible that catalase
enzyme may rapidly clear the H2O2 produced by SOD,
thus favoring a rightward shift for superoxide dismuta-
tion reaction to facilitate O2
- removal. In addition, the
appearance of O2
- in myocytes could be induced by the
external H2O2 [47]. It is plausible to speculate that cata-
lase-induced partial attenuation of O2
- production may
be associated with the reduction of H2O2 levels. Our data
also suggested that damaged mitochondria in response to
a lethal toxin challenge may be related to induction of
autophagy. Although efficient removal of dysfunctional
mitochondria by way of autophagy is critical for the
maintenance of cell homeostasis, excessive autophagy
induction, (in particular, mitophagy), may trigger loss of
ATP production and mitochondrial membrane potential
leading to mitochondrial injury [48,49]. Further study is
warranted to examine the putative mechanisms whereby
alterations in the autophagic removal of damaged mito-
chondria intervene in the process of lethal toxin toxicity.
Ubiquitin proteasome system (UPS) plays an essential
role in regulating a wide variety of cellular pathways,
including cell growth and proliferation, apoptosis, pro-
tein quality control DNA repair, transcription and
immune response [50-52]. UPS degrades both mis-
folded and damaged proteins by covalently attaching
ubiquitin to target proteins followed by proteasomal
degradation of these proteins. Nonetheless, proteasome
functional insufficiency (PFI) often develops under
pathophysiological conditions as a result of impaired
proteasome activity or insufficient activity to cope with
the increased demand. Proteasome functional insuffi-
ciency may lead to decreased degradation of mis-folded
proteins, resulting in accumulation of protein aggregates
to further inhibit proteasomal activities and deteriorate
cellular stress. Increased protein ubiquitination and
aberrant protein aggregation are typical signs of PFI,
which is commonly seen in cardiac proteinopathy, myo-
cardial ischemia-reperfusion injury, idiopathic dilated
cardiomyopathy and hypertrophic cardiomyopathy
[53-55]. PFI may compromise cardiac function through
impairing protein quality control [56]. Data from our
study revealed a significant increase in ubiquitination
accompanied by impaired proteasome activity in
response to lethal toxin challenge. Our data also
revealed a reminiscent inhibitory effect of H2O2 on pro-
teasomal activity, the effect of which was reversed by
the antioxidant NAC. One likely explanation for the
decreased proteasome activity following lethal toxin
exposure could be due to the inactivation of 26S protea-
some subunits by oxidative modification [57]. We and
others have reported overt O2
- accumulation in neutro-
phils, macrophages and myocardium following lethal
toxin exposure [14,20,21]. Inhibition of 26S proteasome
could be caused by oxidative products, such as protein
aggregates, oxidized lipids or by oxidative modification
(4-hydroxy-nonenalyation) of several proteasome subu-
nits [35,42,52]. Moreover, oxidative stress can induce
the dissociation of the 20S core particle from the 19S
regulatory particle of the 26S proteasome, which results
in loss of the activities of the 26S proteasome and thus
results in accumulation of ubiquitinated proteins [22].
Cardiac-specific catalase overexpression effectively miti-
gates lethal toxin-induced impairment of ubiquitin pro-
teasome function (although not in ubiquitin level),
suggesting a possible role of UPS in the antioxidant-
offered beneficial effect against lethal toxin.
Conclusions
Data from our study revealed that the catalase overexpres-
sion rendered cardioprotection against anthrax lethal
toxin. Cardiac catalase overexpression rescues cardiac
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contractile dysfunction and intracellular Ca2+ mishandling
in response to lethal toxin exposure, possibly through alle-
viation of oxidative stress, mitochondrial damage and
autophagy as well as improved UPS proteasomal activity.
These findings have depicted potential therapeutic pro-
mises for molecules capable of scavenging ROS and sup-
pressing autophagy in the clinical management of anthrax
infection-induced cardiovascular complications.
Additional material
Additional file 1: Figure S1: Effect of catalase overexpression on LeTx
exposure-induced changes in intracellular Ca2+ regulatory proteins. A:
Representative gel blots depicting expression of SERCA2a, Na+-Ca2+
exchanger (NCX), phospholamban (PLB), phosphorylated PLB and GAPDH
(used as loading control); B: SERCA2a; C: NCX; and D: phosphorylated-PLB
(p-PLB)-to-PLB ratio. Mean ± SEM, n = 6 mice per group, *P <0.05 vs. WT
group. Figure S2: Effect of autophagy induction or inhibition on lethal
toxin induced cardiac contractile dysfunction. A-B: Isolated
cardiomyocytes from WT and CAT mice were incubated with lethal toxin
(100 ng/ml) for 3 h in presence or absence of the autophagy inhibitor 3-
methyladenine (3-MA, 10 mM) or autophagy inducer rapamycin (5 μM)
respectively. A: Resting cell length; B: time-to-peak shortening (TPS).
Mean ± SEM, n = 60 to 75 cells from three mice per group, *P <0.05 vs.
WT group, # P <0.05 vs. WT-LeTx group.
Abbreviations
± dL/dt: Maximal velocity of shortening/re-lengthening; 3-MA: 3-
methyladenine; CM-H2DCFDA: Fluoroprobe 5-(6)-chloromethyl-2, 7-
dichlorodihydrofluorescein diacetate; DHE: dihydroethidium; ER: Endoplasmic
reticulum; GFP: Green fluorescence protein; LeTx: Anthrax Lethal Toxin; NAC:
N-acetyl-cysteine; PLB, Phospholamban; PS: Peak shortening; ROS: Reactive
oxygen species; SERCA: Sarco(endo)plasmic reticulum Ca2+-ATPase; TPS:
Time-to-90% peak shortening; TR90: Time-to-90% re-lengthening; UPS:
Ubiquitin Proteasome System.
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